CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Feasibility & Acceptability of CHAMPION
研究概览
简要总结
The goal of this randomized controlled trial is to pilot test new mobile health (mHealth) interventions to improve PrEP adherence among HIV-negative men who have sex with men (MSM) with mild to moderate methamphetamine use disorder (MUD). The CHAMPION intervention combines two mHealth tools-PrEPAPP and CBT4CBT-to address both HIV prevention and MUD treatment needs in this population. The study's specific aims are:
- To evaluate the feasibility and acceptability of the CHAMPION intervention based on treatment retention and engagement rates.
- To examine the preliminary efficacy the CHAMPION intervention to improve PrEP adherence, as measured by dried blood spot (DBS) tests compared to the waitlist control group.
详细描述
The CHAMPION (Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM) study, a randomized controlled trial that aims to pilot test state-of-the-art multi-modal pharmaco-behavioral interventions to increase PrEP adherence among HIV-negative MSM who use meth, versus a waitlist control. The study will enroll 100 HIV-negative MSM with mild or moderate meth use disorder (MUD) and sub-optimal PrEP adherence. The study will follow participants for 6 months. The intervention arm will receive the 6-month mHealth intervention package, CHAMPION, at baseline, while the waitlist control will receive it at month-3 follow-up. Results of this pilot study will determine the viability of combining interventions that reduce meth use and enhance PrEP adherence, informing the direction of future interventions for MSM who use meth.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •HIV-negative
- •Cis-gender male
- •Age 18-40 years old
- •Mild or moderate MUD (by DSM-5 SCID criteria)
- •Anal intercourse with one or more male partners in the past 6 months
- •Started daily oral PrEP more than 30 days ago and self-reported not always taking PrEP as prescribed in the past 30 days (consistent with PrEP It! inclusion criteria)
- •Willingness to participate in an mHealth study with a 6-month follow-up
- •Residing in San Diego or San Francisco County
排除标准
- •Residing outside of San Diego or San Francisco County
- •Any condition that, in the principal investigator's judgment interferes with safe study participation or adherence to study procedures
- •Not able/willing to complete virtual/remote visits
- •Not willing to learn to self-collect dried blood spots using a finger stick
研究组 & 干预措施
Waitlist Control Arm
3-month waitlist period including informational resources, followed by 3-month CHAMPION intervention.
干预措施: Delayed CHAMPION Package (Behavioral)
结局指标
主要结局
Feasibility & Acceptability of CHAMPION
时间窗: 6 months
We will calculate the following feasibility and acceptability measures: 1. study completion rate (mean, standard deviation) 2. days of PrEPAPP use (mean, standard deviation) 3. CBT4CBT virtual sessions completed (mean, standard deviation)
PrEP adherence
时间窗: 6-Months
We will examine the preliminary efficacy of CHAMPION vs. a waitlist control on increasing PrEP adherence, compared to a waitlist control as determined by dried blood spot (DBS) tests. In preparation for a larger efficacy trial, we will explore the preliminary efficacy of CHAMPION vs. waitlist control in increasing PrEP adherence. PrEP drug levels in DBS samples will be dichotomized as PrEP adherence, or not, using established cut-offs for protective levels of PrEP. We will calculate the following outcome measure: 1.) Number and percent adherent to PrEP, based on DBS.
次要结局
未报告次要终点
研究者
Kiyomi Tsuyuki
Multi-Principal Investigator
University of California, San Francisco